Scandinavian ChemoTech AB (publ) (FRA:8V6)

Market Cap	9.49M +353.5%
Revenue (ttm)	1.14M +87.1%
Net Income	-744.40K
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.3220
Previous Close	0.3060
Day's Range	0.3220 - 0.3220
52-Week Range	0.0416 - 0.6800
Beta	n/a
RSI	49.57
Earnings Date	Feb 17, 2026

About Scandinavian ChemoTech AB

Scandinavian ChemoTech AB (publ), a medical technology company, engages in the radiation physics, surgical oncology, and clinical development in Sweden and internationally. It operates in two divisions, Human Care and Animal Care. The company offers IQWave, an electroporation that generates a tumour-specific electrical stimulation; and veterinary medicines under the vetIQur name. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2013
• Employees: 1
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8V6

Financial Performance

In 2025, Scandinavian ChemoTech AB's revenue was 12.29 million, an increase of 87.10% compared to the previous year's 6.57 million. Losses were -8.06 million, -41.27% less than in 2024.

Financial numbers in SEK